Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
The AI advisor draws on more than 30 years of debt expertise and carries no affiliate relationships, referral fees, or ...
Blending 60 years of family craft with AI‑driven retail, JewelHub™ introduces a new modular jewellery ecosystem in the ...
February 24, 2026 - PRESSADVANTAGE - In a world increasingly driven by visual content, the ability to efficiently ...
How agentic AI is transforming property inspections, compliance reporting, and maintenance workflows across global real ...
AI-generated images now headline billboards, fill product catalogues, and slip into everyday slide decks—a leap from party trick to mainstream business tool. UK teams want specifics: Which API ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...
I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...
Creating professional-grade videos no longer requires high costs, complex tools, and expert skills. BananaImg AI changes that by offering a unified online platform for AI-powered image and video ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results